US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Anti-Pandemic Concept

1,831.58

-16.3328-0.88%

Number of Gainers:3

Number of Losers:16

Number of Flat:- -

PE:- -

High:1,843.55

Open:1,843.55

Low:1,812.56

Close:1,847.72

Volume:32.08M

Turnover:1.93B

Market Cap:1.49T

Float Cap:1.46T

Loading ...

Equillium to Join Cantor Global Healthcare Conference 2026 Fireside Chat

Lakeland Fire + Safety Awarded Airfield Rescue and Fire Fighting Protective Equipment Contract with Airports of Thailand

THOMSON REUTERS

Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?

Simply Wall St.

BioNTech (BNTX) Halts Cancer Trial, Is The 15% Undervaluation Still Credible?

Simply Wall St.

Johnson & Johnson : UBS Raises Target Price to $320 from $280

THOMSON REUTERS

Pfizer (PFE) Following FDA Vaccine Approval Has Fair Value Back In Focus

Simply Wall St.

Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement

Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors

Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Due 2032

Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day

Moderna Inc. Stock Advances 9.9%, Outperforms Peers

iBio CEO Joins Wells Fargo Annual Healthcare Conference Fireside Chat

Inovio to Present at Cantor Global Healthcare Conference Fireside Chat

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/BK4568/news?page=11"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1831.3878,"timestamp":1789488672128,"preClose":1847.7206,"halted":0,"volume":32077530,"delay":0,"changeRate":-0.008839,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-16.332764,"latestTime":"09-15 12:11:12 EDT","open":1843.5487,"high":1843.552,"low":1812.5594,"amount":1925808504.898354,"amplitude":0.016773,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789502400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.787725,"peRate":46.585694,"turnoverRate":0.002312,"increases":3,"decrements":16,"flats":0,"marketCap":1489931945331,"floatMarketCap":1455784816208},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1843.552,"amplitude":0.016773,"preClose":1847.7206,"low":1812.5594,"pbRate":"4.787725","latestPrice":1831.5752,"volume":32076312,"delay":0,"open":1843.5487,"prevYearClose":1637.1339,"prevWeekClose":1829.725,"prevMonthClose":1860.7577,"prevQuarterClose":1731.2963,"fiveDayClose":1852.4125,"twentyDayClose":1778.7885,"sixtyDayClose":1624.1672,"secType":"PLATE","market":"US","turnoverRate":0.002312,"peRate":46.585694,"marketCap":1489931945331,"floatMarketCap":1455784816208,"timestamp":1789488671778,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":3,"down":16,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:11,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664114718","title":"Equillium to Join Cantor Global Healthcare Conference 2026 Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664114718","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664114718?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:32","pubTimestamp":1788352340,"startTime":"0","endTime":"0","summary":"Equillium to join Cantor Global Healthcare Conference 2026 fireside chatEquillium will join the Cantor Global Healthcare Conference on September 9, 2026, featuring a fireside chat at 9:45 a.m. EDT.Man","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL82vS7l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","NDAQ","LU2095319765.USD","BK4568","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","LU2210149790.SGD","BCDF","LU2210150020.SGD","IE00BGHQF748.EUR","SG9999014021.USD","IE00BKPKM429.USD","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","IE00BN0W2W23.USD","BK4112","BK4139","IE00BQXX3C00.GBP","LU0314104364.USD","BK4588","SG9999014013.SGD","SG9999014039.USD","IE00BN0W2V16.EUR","EQ","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664981148","title":"Lakeland Fire + Safety Awarded Airfield Rescue and Fire Fighting Protective Equipment Contract with Airports of Thailand","url":"https://stock-news.laohu8.com/highlight/detail?id=2664981148","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664981148?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:31","pubTimestamp":1788352260,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nTUA2RBMJ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE0031619046.USD","IE00B66KJ199.SGD","LAKE","BK4568","IE00B19Z4B17.USD","BK4202","IE00B7SZL793.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664381433","title":"Is Gilead Sciences (GILD) Fully Valued On Its New HIV And Cancer Drug Approvals?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664381433","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664381433?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:23","pubTimestamp":1788348209,"startTime":"0","endTime":"0","summary":"Gilead Sciences (GILD) has drawn fresh investor attention after two recent regulatory decisions. The FDA approved Bixlenvo for virologically suppressed adults with HIV, and the European Commission cleared Trodelvy plus Keytruda for certain metastatic triple-negative breast cancer patients.\nThese approvals arrive after a strong run in Gilead Sciences' stock, with a 30-day share price return of 15.14% and a year-to-date share price return of 23.29%, alongside a 36.48% 1-year total shareholder...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/is-gilead-sciences-gild-fully-valued-on-its-new-hiv-and-canc","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999015978.USD","IE0002270589.USD","BK4578","LU0109394709.USD","LU0289739699.SGD","LU1585245621.USD","LU1934455194.USD","SG9999015952.SGD","SG9999015986.USD","BMED","LU2089984988.USD","BIB","IE00BZ1G4Q59.USD","LU2112291526.USD","LU1037948541.HKD","LU1061106388.HKD","BBH","TBXU","LU1934455863.HKD","MEDI","BK4532","LU1674673428.USD","LU0859254822.USD","LU0882574055.USD","BK4585","LU1066053197.SGD","GILD","IBB","BK4568","TMED","BK4139","IBBQ","IE00B7SZLL34.SGD","LU0889565916.HKD","LU0823416689.USD","LU0965509283.SGD","LU1674673691.USD","LU0114720955.EUR","LU1023059063.AUD","LU1066051498.USD","LU0965509101.SGD","LU0058720904.USD","LU1778281490.HKD","BK4566","LU0122379950.USD","LU2087621335.USD","LU2324357040.USD","IE00B19Z3581.USD","IE00B3T34201.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664814865","title":"BioNTech (BNTX) Halts Cancer Trial, Is The 15% Undervaluation Still Credible?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664814865","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664814865?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:22","pubTimestamp":1788348152,"startTime":"0","endTime":"0","summary":"BioNTech (NasdaqGS:BNTX) has halted a Phase 2 trial of its individualized mRNA cancer immunotherapy autogene cevumeran in high risk colorectal cancer after an independent Data Safety Monitoring Board recommended stopping the study for futility.\nBioNTech’s recent news flow mixes setbacks and progress, with the termination of this colorectal cancer trial arriving shortly after fresh lung cancer data and an FDA approval for the updated COMIRNATY XFG COVID-19 vaccine. The 7 day share price return...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bntx/biontech/news/biontech-bntx-halts-cancer-trial-is-the-15-undervaluation-st","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-bntx/biontech/news/biontech-bntx-halts-cancer-trial-is-the-15-undervaluation-st","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","BK4588","BK4568","BK4551","BNTX","BK4548","BK4585","BK4535"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815119","title":"Johnson & Johnson : UBS Raises Target Price to $320 from $280","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815119?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:02","pubTimestamp":1788346971,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nAZN4THURS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JNJ","LU2471134523.USD","LU0053666078.USD","LU0792757196.USD","BK4533","XLV","LU1145028129.USD","BMED","JDOC","FTXH","BK4592","LU1066053197.SGD","IYH","BK4534","VHT","LU0795875169.SGD","LU1066051498.USD","LU1929549753.HKD","LU1059921491.USD","BK4568","TRUH","LU0072461881.USD","GDOC","LU0912757837.SGD","LU0289739699.SGD","FHLC","LU2430703178.SGD","LU0985320562.USD","LU1244550494.USD","LU1914381329.SGD","LU0345770308.USD","LU0345770993.USD","LU0426412945.USD","LU2089984988.USD","MEDX","IE000BZT7R73.USD","SG9999001440.SGD","LU1228905037.USD","RXL","IE00B42XCP33.USD","IXJ","LU0098860793.USD","LU0210528500.USD","PJP","LU0210536198.USD","IHE","IE00BLSP4239.USD","LU1778281490.HKD","SG9999013999.USD","LU1983299246.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664895425","title":"Pfizer (PFE) Following FDA Vaccine Approval Has Fair Value Back In Focus","url":"https://stock-news.laohu8.com/highlight/detail?id=2664895425","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664895425?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:22","pubTimestamp":1788319369,"startTime":"0","endTime":"0","summary":"Why the new COVID-19 vaccine approval matters for Pfizer stock\nPfizer (PFE) and BioNTech just received FDA approval for their 2026 to 2027 COMIRNATY XFG COVID-19 vaccine for certain higher risk groups, a decision that opens the door to fresh U.S. vaccine shipments.\nPfizer’s share price has picked up recently, with a 30 day share price return of 14.15% and a 90 day share price return of 12.67%. The 1 year total shareholder return of 22.31% comes after several years of weaker total returns...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/162270-main-header/1756254067137"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/pfizer-pfe-following-fda-vaccine-approval-has-fair-value-bac","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-pfe/pfizer/news/pfizer-pfe-following-fda-vaccine-approval-has-fair-value-bac","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0234572021.USD","LU0321505868.SGD","PFE","SG9999001176.USD","SG9999002224.SGD","BK4592","LU0289739699.SGD","IE00B3T34201.USD","SG9999011175.SGD","LU0225284248.USD","BK4534","BK4599","LU1894683264.USD","LU0985481810.HKD","BK4533","LU1894683348.USD","LU1057294990.SGD","LU2596442595.SGD","SG9999002232.USD","LU1023059063.AUD","LU0868494617.USD","IE00BLSP4452.SGD","LU0170899867.USD","BK4588","SG9999013999.USD","LU1066053197.SGD","IE0002270589.USD","LU0122379950.USD","LU1883839398.USD","LU0058720904.USD","SG9999001176.SGD","SG9999003800.SGD","IE000M9KFDE8.USD","IE00B19Z3581.USD","LU0306807586.USD","BK4585","LU0225771236.USD","IE00BLSP4239.USD","BK4581","OZEM","LU0456855351.SGD","LU1066051498.USD","SGXZ57979304.SGD","LU0306806265.USD","BK4568","BK4550","BK4007","LU0321505439.SGD","IE00B19Z3B42.SGD","IE00BBT3K403.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664386900","title":"Johnson & Johnson EVP Thomas Cavanaugh Files Initial Beneficial Ownership Statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2664386900","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664386900?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:53","pubTimestamp":1788295990,"startTime":"0","endTime":"0","summary":"Johnson & Johnson EVP Thomas Cavanaugh files initial beneficial ownership statementJohnson & Johnson EVP WW Chair, Innovative Med. Thomas Cavanaugh filed a Form 3 disclosing 499 common shares, includi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL58rn8Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PJP","LU1032466523.USD","BK4568","JDOC","MEDX","LU2487616109.SGD","JNJ","IXJ","LU0964807845.USD","LU0994945656.USD","LU1929549753.HKD","LU2750360997.AUD","RXL","LU0943347566.SGD","LU2602419157.SGD","LU0545562505.USD","LU1430594728.SGD","LU0689472784.USD","IE00BVYPNV92.GBP","IE00BKVL7J92.USD","LU1228905540.USD","LU2430703251.USD","LU0203347892.USD","TRUH","LU0289739699.SGD","IE000F7OJYX1.SGD","LU1732800096.USD","LU2213496289.HKD","LU2133065610.SGD","FTXH","IE00B19Z3581.USD","BMED","XLV","LU0234572021.USD","IE00BLSP4452.SGD","LU1496350502.SGD","IE00BJT1NW94.SGD","IE00BVYPNW00.USD","LU1221951046.USD","VHT","GDOC","IE00BJJMRZ35.SGD","LU2112291526.USD","BK4504","IYH","IE000WAW04H5.SGD","IE00BSNM7G36.USD","SG9999013999.USD","FHLC","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664869005","title":"Estee Lauder Cos. Cl a Stock Underperforms Tuesday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664869005","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664869005?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:53","pubTimestamp":1788295980,"startTime":"0","endTime":"0","summary":"DJ Estee Lauder Cos. Cl A Stock Underperforms Tuesday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Estee Lauder Cos. Cl A  shed 2.25% to $100.00 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.71% to 7,631.47 and Dow Jones Industrial Average  falling 0.79% to 52,766.88.This was the stock's third consecutive day of losses.Estee Lauder Cos. Cl A closed 17.79% short of its 52-week high of $121.64, which the company reached on February 3rd.The stock underperformed when compared to some of its competitors Tuesday, as Johnson & Johnson  rose 2.01% to $271.19, Procter & Gamble Co.  rose 0.75% to $146.21, and Coty Inc. Cl A  fell 0.35% to $2.84.Trading volume  remained 177,738 below its 50-day average volume of 3.1 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","SG9999014542.SGD","XLP","LU2471134879.HKD","RXL","LU0882574055.USD","LU0795875169.SGD","TRUO","IE00BZ1G4Q59.USD","XLV","COTY","IE000F7OJYX1.SGD","LU0432979614.USD","IHE","BMED","FTXH","LU0098860793.USD","IYH","SG9999014559.SGD","JDOC","IXJ","BK4568","LU0289739699.SGD","LU1551013342.USD","FSTA","IE00B19Z3B42.SGD","LU2404859667.USD","LU0072461881.USD","LU0122379950.USD","TRUH","MEDX","GDOC","GLAM","LU1894683348.USD","LU0234572021.USD","LU0210536198.USD","IE00B2B36J28.USD","UGE","LU0237698245.USD","LU1057294990.SGD","IE00BVYPNV92.GBP","LU1059921491.USD","PG","PJP","JNJ","IE00BDGV0183.EUR","EL","VHT","FHLC","LU1267930813.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664486915","title":"Moderna Plans Private Placement of $2 Billion Convertible Senior Notes Due 2032","url":"https://stock-news.laohu8.com/highlight/detail?id=2664486915","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664486915?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:37","pubTimestamp":1788295066,"startTime":"0","endTime":"0","summary":"Moderna plans private placement of $2 billion convertible senior notes due 2032Moderna launched a private placement of USD 2 billion Convertible Senior Notes due 2032, marketed to qualified institutio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL75wNqt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IDNA","MRNY","WDNA","BK4548","BK4534","BK4568","BK4532","BK4501","BK4588","GNOM","MRNA","BK4533","BK4139","LGHT","BK4551","MRNX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664999869","title":"Gilead Sciences Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2664999869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664999869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:35","pubTimestamp":1788294900,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  rallied 2.45% to $149.92 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 0.71% to 7,631.47 and Dow Jones Industrial Average  falling 0.79% to 52,766.88.This was the stock's second consecutive day of gains.Gilead Sciences Inc. closed 4.69% short of its 52-week high of $157.29, which the company reached on February 11th.The stock outperformed some of its competitors Tuesday, as Johnson & Johnson  rose 2.01% to $271.19, Pfizer Inc.  rose 0.32% to $28.55, and Abbott Laboratories  fell 1.30% to $108.93.Trading volume  remained 2.1 million below its 50-day average volume of 6.9 M.Data source: Dow Jones Market Data, FactSet. Data compiled September 1, 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","LU1037948541.HKD","LU1037948897.HKD","BK4566","TMED","LU0859254822.USD","LU0861579265.USD","BK4583","LU1674673428.USD","IE00B3T34201.USD","LU1839511570.USD","LU0289739699.SGD","BK4585","BMED","LU0823416689.USD","SG9999015945.SGD","GILD","LU0234570918.USD","LU1778281490.HKD","LU2468319806.SGD","SG9999015978.USD","BK4588","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU2324357040.USD","IE0002270589.USD","LU1934455277.USD","LU2357627491.SGD","LU0122379950.USD","LU0965508806.USD","LU1934455863.HKD","BK4568","IE00B19Z3581.USD","LU0320765992.SGD","IE00BZ1G4Q59.USD","LU0965509283.SGD","LU2112291526.USD","SG9999015986.USD","IBB","LU1934455194.USD","LU0114720955.EUR","LU0889565916.HKD","BK4578","IBBQ","BK4532","LU1430594728.SGD","TBXU","LU0882574055.USD","LU0965509010.AUD","LU1066051498.USD","LU1571399168.USD","LU1585245621.USD","LU1674673691.USD","IE00B7SZLL34.SGD","LU2087621335.USD","LU0109394709.USD","BK4139","IE00BSNM7G36.USD","LU0058720904.USD","BIB","LU1066053197.SGD","LU1057294990.SGD","LU0965509101.SGD","LU1061106388.HKD","MEDI","BK4550","BBH","LU1023059063.AUD","SG9999015952.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664901869","title":"Moderna Inc. Stock Advances 9.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2664901869","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664901869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:33","pubTimestamp":1788294780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rallied 9.9% to $154.27 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,099.77 and Dow Jones Industrial Average falling 0.8% to 52,766.88.This was the stock's second consecutive day of gains.Moderna Inc. closed 12.7% short of its 52-week high of $176.66, which the company achieved on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 2.0% to $271.19, Pfizer Inc. rose 0.3% to $28.55, and Gilead Sciences Inc. rose 2.45% to $149.92.Trading volume totaled 25.3 million, compared to the 50-day average of 16.8 million.Data source: Dow Jones Market Data, FactSet","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","IDNA","LU2112291526.USD","MRNY","BK4588","LU0823416689.USD","BK4583","IBB","LU2468319806.SGD","LU2324357040.USD","BK4566","IE00BZ1G4Q59.USD","BK4501","MEDI","BK4568","LU0109394709.USD","LU0289739699.SGD","GNOM","MRNA","BK4534","LU0965509010.AUD","LU2089984988.USD","BBH","IE00B7SZLL34.SGD","BK4533","IBBQ","LU1057294990.SGD","IE00B19Z3B42.SGD","TBXU","WDNA","LU0234570918.USD","BIB","BMED","BK4139","LU0320765992.SGD","BK4551","LU1934455863.HKD","MRNX","SG9999015945.SGD","LU1934455277.USD","LU1571399168.USD","LU1066053197.SGD","LU1934455194.USD","TMED","LGHT","LU0861579265.USD","LU1430594728.SGD","LU0058720904.USD","LU1037948541.HKD","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664680869","title":"iBio CEO Joins Wells Fargo Annual Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664680869","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664680869?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:30","pubTimestamp":1788294652,"startTime":"0","endTime":"0","summary":"iBio CEO joins Wells Fargo Annual Healthcare Conference fireside chatiBio will attend the Wells Fargo 21st Annual Healthcare Conference in Boston on Sept. 8-10, 2026.CEO Martin Brenner will join a fir","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL7TVsbc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NDAQ","IE00BN0W2W23.USD","IE00BKPKM429.USD","SG9999014013.SGD","IE00BQXX3F31.USD","BK4139","BCDF","LU0314104364.USD","LU2210149790.SGD","SG9999014039.USD","BK4112","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00BQXX3C00.GBP","IE00BGHQF748.EUR","SG9999014005.SGD","BK4585","IBIO","IE00B64PRP62.GBP","BK4568","IE00B3QW5Z07.USD","SG9999014021.USD","LU2210150020.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664866473","title":"Inovio to Present at Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664866473","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664866473?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:06","pubTimestamp":1788293187,"startTime":"0","endTime":"0","summary":"Inovio to present at Cantor Global Healthcare Conference fireside chatInovio will take part in the Cantor Global Healthcare Conference in New York on September 9, including a 3:20 p.m. ET fireside cha","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL3Wq6HN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","INO","BK4139","BK4583"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":11,"pageCount":11,"totalSize":213,"code":"91000000","status":"200"}]}}